Physician profile
Wayne Hellstrom
NPI 1689767980
$183,324.94
in general payments reported to CMS, 2019-2025
19 companies · $13K in 2025
The $13K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $67K · 2021: $13K · 2022: $17K · 2023: $16K · 2024: $3,149 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $6,386 · Travel and Lodging: $2,677 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,850.00 |
| Food and Beverage | $6,386.20 |
| Travel and Lodging | $2,676.74 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $70,631.57 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $53,804.35 | 2019-2023 | Xiaflex |
| Boston Scientific Corporation | $24,348.52 | 2019-2025 | Ams 700, Ams 700 Cxr Rte Kit, Advance Xp |
| Endo USA, INC. | $11,933.90 | 2024-2025 | Xiaflex |
| Jazz Pharmaceuticals INC. | $8,000.00 | 2023-2024 | Jzp-150 |
| Coloplast Corp | $7,192.14 | 2019-2025 | Titan |
| Acerus Pharmaceuticals Corporation | $3,265.95 | 2020-2022 | |
| Antares Pharma, INC. | $2,620.74 | 2019-2023 | Xyosted, Tlando |
| Clarus Therapeutics INC. | $395.69 | 2021 | |
| Astellas Pharma US INC | $354.65 | 2021-2024 | Xtandi |
| Procept Biorobotics Corporation | $166.44 | 2024 | Aquabeam System |
| Teleflex LLC | $160.09 | 2020-2024 | |
| Cook Medical LLC | $135.32 | 2019-2025 | Litho 150 |
| Bard Access Systems, INC. | $120.30 | 2019 | |
| Karl Storz Endoscopy-America | $64.55 | 2023 | Flex-X |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $63.12 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $25.01 | 2023 | Lynparza |
| Myriad Genetic Laboratories, INC. | $21.77 | 2021 | |
| Laborie Medical Technologies Corp. | $20.83 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Hellstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.